Summary & Overview
CPT 32994: Percutaneous Cryoablation of Lung, Pleura, or Chest Wall Tumor
CPT code 32994 covers unilateral percutaneous cryoablation of tumors in the lung, pleura, or chest wall using a wandlike cryoprobe, with imaging guidance included. This minimally invasive thoracic procedure is increasingly relevant as image-guided ablation options expand for primary and metastatic lung lesions and for palliative control of chest-wall or pleural disease. Nationally, the code is used across hospital outpatient departments, ambulatory surgery centers, and interventional radiology suites.
Key payers covered in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical service and typical sites of care, plus an outline of the policy and billing considerations commonly associated with image-guided thoracic ablation procedures. The publication provides benchmarks where available, notes on payer coverage patterns, and summaries of clinical context that influence coding and utilization. Where specific inputs are not provided in the source data, the report states that the information is not available.
This summary equips coding managers, revenue cycle staff, and clinical leaders with a clear understanding of what CPT code 32994 represents, why it matters in contemporary thoracic oncology and interventional practice, and what national payers typically consider when evaluating coverage for percutaneous cryoablation services.
Billing Code Overview
CPT code 32994 describes a unilateral percutaneous cryoablation of lung, pleura, or chest wall tumor. The procedure uses a minimally invasive approach in which a wandlike needle (cryo probe) is introduced into the chest cavity to destroy tumor tissue by freezing. Imaging guidance, when used, is included in the code description.
Service type: Percutaneous image-guided tumor ablation
Typical site of service: Hospital outpatient department, ambulatory surgery center, or other procedural suite capable of image-guided thoracic interventions
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient with a history of primary non-small cell lung carcinoma presents with a single 2.5 cm peripheral pulmonary nodule in the right lower lobe confirmed by recent CT and PET imaging. The multidisciplinary tumor board determines the patient is a poor candidate for lobectomy due to limited pulmonary reserve and comorbidities (chronic obstructive pulmonary disease and coronary artery disease). Percutaneous image-guided cryoablation is planned as a unilateral, minimally invasive approach to locally control the tumor.
The clinical workflow includes pre-procedure evaluation (history, focused pulmonary and cardiac assessment, review of recent imaging), informed consent, review of anticoagulation status, and anesthesia planning (conscious sedation or general anesthesia depending on comorbidity and lesion location). In the interventional suite or hybrid operating room, CT or fluoroscopic imaging is used to guide percutaneous insertion of one or more cryoprobes into the target lesion. Multiple freeze–thaw cycles are applied to achieve an ablation zone with margin. Post-procedure imaging is obtained to confirm expected changes and to identify complications such as pneumothorax. The patient is observed for respiratory compromise and discharged same day or after an overnight stay depending on clinical status.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier — standard reporting | Used when no modifier applies and the service is reported as a routine claim. |